This leads to the upregulation of hypoxia-related genes, such as vascular endothelial growth factor (VEGF) and glucose-transporter-1 (GLUT1) which accelerate the aggressive phenotype of HLRCC-related kidney tumors [5]. Here, VEGFA is linked to hereditary leiomyomatosis and renal cell cancer.